Comparative in vitro study in new cephalosporins

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Emerging antibiotic resistance necessitates the evaluation of novel antimicrobial agents.
• Cephalosporins are a critical class of antibiotics used to treat bacterial infections.

Purpose of the Study:

• To evaluate the in vitro activity of three new cephalosporins: ceftazidime, ceftizoxime, and cefotiam.
• To compare their efficacy against clinical isolates with existing cephalosporins, mezlocillin, and tobramycin.

Main Methods:

• In vitro susceptibility testing of clinical bacterial isolates.
• Comparative analysis of antibiotic activity against various Gram-positive and Gram-negative pathogens.

Main Results:

• Ceftazidime, ceftizoxime, and cefotiam exhibited significant activity against Gram-positive cocci, excluding enterococci.
• Ceftazidime demonstrated broad-spectrum efficacy against Gram-negative bacilli, with exceptions including Enterobacter spp.
• Ceftizoxime was effective against most Gram-negative bacilli, with noted inactivity against Enterobacter spp. and Pseudomonas aeruginosa.
• Cefotiam showed activity against common Gram-negative bacteria like E. coli and K. pneumoniae but was inactive against P. aeruginosa and indole-positive Proteus.

Conclusions:

• Ceftazidime exhibits promising broad-spectrum activity against Gram-negative bacilli, suggesting its utility in treating infections where these bacteria are prevalent.
• The study highlights the differential activity profiles of the new cephalosporins, guiding their potential clinical applications.